Diabetes and obesity drugs also lead to large reductions in adverse cardiovascular events, and the benefits aren’t just down to weight loss.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/glp-1-drugs-gain-ground-cardiovascular-prevention-2026a1000759?src=rss
Author :
Publish date : 2026-03-09 14:28:00
Copyright for syndicated content belongs to the linked Source.
